about
Metabolism of human immunoglobulin D (IgD)Unraveling the Interaction between FcRn and Albumin: Opportunities for Design of Albumin-Based TherapeuticsPostnatal decline of maternally acquired rubella antibodiesThe mechanism of intestinal uptake and transcellular transport of IgG in the neonatal ratHyperimmunoglobulinaemia, T-cell deficiency and plasmacytosis in RFM mice with host versus graft disease induced by the perinatal inoculations (T6XRFM)F1 spleen cells.Catabolism of human serum IgG in health, rheumatoid arthritis, and active tuberculous disease. Possible influence of IgG structure.The effects of prednisone and azathioprine on circulating immunoglobulin levels and lymphocyte subpopulations in normal dogsMETABOLISM OF HUMAN GAMMA MACROGLOBULINS.Immunoglobulin changes in disease: quantitation on the basis of heavy polypeptide chains, IgG (gammaG), IgA (gammaA), and IgM (gammaM), and of light polypeptide chains, type K (I) and type L (II)Hypogammaglobulinemia associated with accelerated catabolism of IgG secondary to its inteaction with an IgG-reactive monoclonal IgMIGG (7 S GAMMA GLOBULIN) METABOLISM IN HYPOGAMMAGLOBULINEMIA: STUDIES IN PATIENTS WITH DEFECTIVE GAMMA GLOBULIN SYNTHESIS, GASTROINTESTINAL PROTEIN LOSS, OR BOTHAccelerated breakdown of immunoglobulin G (IgG) in myotonic dystrophy: a hereditary error of immunoglobulin catabolism.Catabolism of human gammaG-immunoglobulins of different heavy chain subclasses. I. Catabolism of gammaG-myeloma proteins in man.IgG is transported across the mouse yolk sac independently of FcgammaRIIb.Metabolic properties of IgG subclasses in man.Recent advances using FcRn overexpression in transgenic animals to overcome impediments of standard antibody technologies to improve the generation of specific antibodies.THE IMMUNOGLOBULINS OF MICE. V. THE METABOLIC (CATABOLIC) PROPERTIES OF FIVE IMMUNOGLOBULIN CLASSESResistance to Trastuzumab in Breast Cancer.Beta2-microglobulin-deficient mice are resistant to bullous pemphigoid.Inhibitors of the FcRn:IgG protein-protein interaction.Accelerating antibody discovery using transgenic animals overexpressing the neonatal Fc receptor as a result of augmented humoral immunity.The effect of azathioprine on gammaglobulin synthesis in manHypercatabolism of normal IgG; an unexplained immunoglobulin abnormality in the connective tissue diseasesAltered immunoglobulin metabolism in systemic lupus erythematosus and heumatoid arthritis.Metabolism of bovine immunoglobulin. I. Metabolism of bovine IgG in cattle with chronic pyogenic infectionsTHE CATABOLISM OF HOMOLOGOUS AND HETEROLOGOUS 7S GAMMA GLOBULIN FRAGMENTS.Albumin and immunoglobulin turnover in patients with chronic active liver disease treated with prednisone.IgG Fc engineering to modulate antibody effector functions.The formation in vitro of paraproteins in multiple myeloma and Waldenström's macroglobulinaemia.Sex-linked factor influencing the catabolism of serum gammaG-globulins and transferrins in the mouse.Metabolism of gamma-G-globulin in the nephrotic syndrome in adults.Placental transfer of an IgG paraprotein associated with prolonged immunosuppression.Treatment with Low Doses of Polyclonal Immunoglobulin Improves B Cell Function During Immune Reconstitution in a Murine ModelFamily studies of immunoglobulin levels in IraqBreakdown Rate of Serum 7S γ-Globulins in MiceBiological Half-life of Mouse Transferrins
P2860
Q24626193-5704C25D-0076-4453-BC5A-83AB23BD49B1Q27027238-DFD7C8FF-23AD-4DB6-B32D-CF9266C03782Q27483309-A14CE73D-94A8-4EE2-9000-1579958D2406Q29027111-6F8C02ED-3CB2-494A-BBDD-D888A4C6529DQ33332549-63103896-935D-4AA5-A9BA-9B4224F9CE02Q33568537-CC28F27C-ACA1-4092-A968-1118A8A059F9Q33923505-2F37E91E-1E31-427C-A436-EE2BD241B59EQ33956353-737963A3-B1F5-4D69-9FAA-FA93B3B7627EQ33960524-BE5FAE45-B6E7-4A8F-9E2F-5168068236D5Q34060101-4E557806-C4CB-4223-9256-3BA9ECC803AFQ34079819-F41AF006-496A-49E2-8FE9-A9DD650B0139Q34080763-3FC8A809-885E-44D8-A634-9E25C8B2BA26Q34279598-C65BE6D5-D934-471E-A197-D8ACC915204CQ34631875-4B80EBC0-636A-45CF-8220-C4AE39A00D2FQ35576283-F6A6E0FF-3464-46B6-A3DB-B6B73C158FC6Q35578023-946EC910-E172-43F1-B6E3-14026E499E4EQ36267537-A998B105-9441-4772-B73A-491674184D7DQ36318226-D7989968-5F8B-4FDA-878E-1E9A5BB7A9F3Q36380468-4C416B87-F48E-4628-BABF-03E2ED84C4F4Q37508794-70A497DC-6871-4DA6-B8AB-C82BBB3956B3Q38615389-63B4FEC0-2064-4F60-903A-7F02FCDDA531Q40326474-2802D7B0-285A-4824-99BB-2D0325267B53Q40474287-DF18ADF2-6EBC-48F0-A78B-31A5A49A1E53Q40474450-CE9CBF6E-11FD-4278-BC73-3CB23E98BDC3Q41276465-F0CFEC9F-6549-4936-9242-99758C18DA82Q42829667-F470E1CE-3B51-42B3-9F2A-1948500D5DD8Q44394475-3891BD28-E97B-47A6-924C-04E5656BAC39Q47593242-0FC1EDF5-182F-416D-83F6-1AC919E5E8FCQ47717991-D8670211-15FC-4418-9AC8-886B9E192D50Q53858729-3D95ACFD-7FAB-4DA6-A243-36CD0A630EC5Q54579366-F91D9981-7413-434A-9BA5-64A642CABFC7Q55108870-863888F4-40DA-4663-B983-1753BC22E52AQ57640701-C5DE4613-90EF-459B-936E-D4CC5BE38A5AQ58176524-480B78CD-2ADF-405C-BCAA-957AF4D5BD77Q58976426-99272A57-B600-46B7-B924-E839256E84C5Q58997272-F8243E13-15E5-45EB-8838-216C36A6CE28
P2860
description
1963 nî lūn-bûn
@nan
1963年の論文
@ja
1963年学术文章
@wuu
1963年学术文章
@zh-cn
1963年学术文章
@zh-hans
1963年学术文章
@zh-my
1963年学术文章
@zh-sg
1963年學術文章
@yue
1963年學術文章
@zh
1963年學術文章
@zh-hant
name
FACTORS CONTROLLING SERUM GAMMA-GLOBULIN CONCENTRATION
@ast
FACTORS CONTROLLING SERUM GAMMA-GLOBULIN CONCENTRATION
@en
type
label
FACTORS CONTROLLING SERUM GAMMA-GLOBULIN CONCENTRATION
@ast
FACTORS CONTROLLING SERUM GAMMA-GLOBULIN CONCENTRATION
@en
prefLabel
FACTORS CONTROLLING SERUM GAMMA-GLOBULIN CONCENTRATION
@ast
FACTORS CONTROLLING SERUM GAMMA-GLOBULIN CONCENTRATION
@en
P2860
P356
P1476
FACTORS CONTROLLING SERUM GAMMA-GLOBULIN CONCENTRATION
@en
P2093
P2860
P304
P356
10.1084/JEM.118.5.845
P407
P577
1963-11-01T00:00:00Z